Lowering inhaled steroids for tezepelumab-treated asthma patients
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial looks at whether people with severe asthma who are taking the biologic tezepelumab can safely reduce their use of inhaled corticosteroids (ICS). It aims to see if reducing or stopping ICS affects asthma symptoms or flare-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with severe asthma.
- You have received or are scheduled to receive at least one dose of tezepelumab.
- You are willing to come to Franciscus hospital if you have an asthma flare-up.
- You understand Dutch or English well enough to follow the study instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a drug called tezepelumab for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this drug can reduce asthma attacks and improve symptoms.
This trial tests if a drug called Tezepelumab can help adults with asthma who visit the emergency room. It aims to reduce severe asthma attacks and improve breathing control.
This study tests whether a physical activity program can help people with severe asthma achieve better control and reduce flare-ups when added to a new treatment called tezepelumab.
This study looks at whether tezepelumab, a biologic medication, can help people with allergic bronchopulmonary aspergillosis (ABPA) and severe asthma. It aims to reduce asthma attacks and improve breathing.
This study asks adults with severe asthma who have been on biologic treatments for at least 6 months to share their educational needs in interviews. The goal is to improve support for people using these therapies.
This trial tests whether adding an allergy immunotherapy tablet (which helps your immune system get used to dust mites) to a biologic treatment (tezepelumab, which reduces airway inflammation) can keep severe asthma under control better than the biologic alone. It may help reduce asthma attacks and improve daily symptoms.
Hear when a new Severe Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.